Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Dividend investing for retirement -- Ignore unavailable to you. Want to Upgrade?

To: Ditchdigger who wrote (33861)	10/29/2021 8:29:19 AM
From: E_K_S	Read Replies (4) \| Respond to of 34328

I had ABBV & GILD as my Pharma w/ the best value metric based on PE, div yield and Price/earnings growth. Still amazed on MRK's breakout and have been peeling off MRK shares and putting proceeds into ABBV & GILD. ABBV +2,72% after their earnings report and see that GILD -1.69% on new BICSTaR data. -------------------------------------------------- Do you have any other Div payers on your list where I might pit some of the MRK proceeds into. MPW was an option but it was upgraded earlier this week and +6%. I have been looking at PHARMA and REITs. Maybe IBM may/could be an option w/ it's recent sell off